Venmax Drugs & Pharmaceuticals Ltd.BSE: VENMAX

Board Meeting Outcome for Outcome Of Board Meeting

· Issued by Venmax Drugs & Pharmaceuticals Ltd. via BSE India

Filed with BSE ·

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has approved the unaudited Standalone Financial Results for the quarter and Half Year ended 30th September, 2024.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix

Later from Venmax Drugs & Pharmaceuticals

All Venmax Drugs & Pharmaceuticals news releases